Table 1.
Preclinical Study Morphometric Measurements, Plasma Biochemical Analysis, and Hepatic Isoprostane Content Analysis
| Hepatic Isoprostane Content (ng/g) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Body Mass (g) | Liver Mass (g) | ALT (U/L) | AST (U/L) | ALP (U/L) | F2-III | F2-IV | F2-VI | |
| Control | 220 ± 33 | 10.8 ± 0.8 | 49 ± 8 | 71 ± 6 | 290 ± 17 | 1.4 ± 0.3 | 0.06 ± 0.19 | 1.7 ± 0.2 |
| CCl4 | 243 ± 27 | 11.6 ± 0.8 | 378 ± 84 | 950 ± 378 | 281 ± 27 | 46.7 ± 10.9 | 0.90 ± 0.19 | 36.4 ± 3.2 |
| HFHC diet | 527 ± 67 | 17.0 ± 3.1 | 74 ± 34 | 200 ± 140 | 136 ± 43 | 20.2 ± 2.8 | 0.60 ± 0.14 | 5.7 ± 1.3 |
Abbreviation: ALP, alkaline phosphatase.